JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥4,758,000 | ¥5,508,000 | ¥5,412,000 | ¥19,404,000 |
| Dep. & Amort. | ¥3,374,000 | ¥3,197,000 | ¥1,997,000 | ¥1,945,000 |
| Deferred Tax | ¥0 | ¥0 | -¥9,221,000 | -¥3,074,000 |
| Stock-Based Comp. | ¥0 | ¥71,000 | ¥173,000 | ¥177,000 |
| Change in WC | -¥328,000 | -¥6,055,000 | -¥2,956,000 | -¥9,030,000 |
| Other Non-Cash | -¥3,774,000 | ¥6,591,000 | -¥905,000 | -¥133,000 |
| Operating Cash Flow | -¥5,486,000 | ¥9,312,000 | -¥5,500,000 | ¥9,289,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥9,888,000 | -¥2,095,000 | -¥8,560,000 | -¥11,333,000 |
| Net Acquisitions | ¥145,000 | -¥600,000 | -¥6,717,000 | ¥8,167,000 |
| Inv. Purchases | ¥0 | ¥0 | -¥906,000 | -¥300,000 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥259,000 | ¥300,000 |
| Other Inv. Act. | -¥131,000 | ¥5,000 | ¥922,000 | -¥84,000 |
| Investing Cash Flow | -¥9,874,000 | -¥2,690,000 | -¥15,002,000 | -¥3,250,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥14,805,000 | ¥500,000 | ¥4,700,000 | -¥20,000 |
| Stock Issued | ¥21,000 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥2,530,000 | ¥15,000 | ¥10,000 | ¥10,000 |
| Dividends Paid | -¥2,505,000 | -¥2,500,000 | -¥2,739,000 | -¥2,169,000 |
| Other Fin. Act. | -¥55,000 | -¥46,000 | -¥23,000 | ¥0 |
| Financing Cash Flow | ¥9,736,000 | -¥2,031,000 | ¥1,948,000 | -¥2,179,000 |
| Forex Effect | ¥64,000 | ¥886,000 | ¥1,099,000 | ¥612,000 |
| Net Chg. in Cash | -¥5,560,000 | ¥5,478,000 | -¥17,455,000 | ¥4,473,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥18,756,000 | ¥13,278,000 | ¥30,733,000 | ¥26,260,000 |
| End Cash | ¥13,196,000 | ¥18,756,000 | ¥13,278,000 | ¥30,733,000 |
| Free Cash Flow | -¥15,374,000 | ¥7,217,000 | -¥14,060,000 | -¥2,044,000 |